Detalhe da pesquisa
1.
P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.
Purinergic Signal
; 19(4): 685-697, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854856
2.
Progress in the relationship between P2X7R and colorectal cancer.
Mol Biol Rep
; 50(2): 1687-1699, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417079
3.
The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
J Immunol
; 205(7): 1752-1762, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868411
4.
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China: A Real-World Nationwide Registry.
Stroke
; 52(4): 1203-1212, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596674
5.
Production, characterization, and application of a monoclonal antibody specific for the extracellular domain of human P2X7R.
Appl Microbiol Biotechnol
; 104(5): 2017-2028, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930453
6.
Overexpression of modified human TRß1 suppresses the growth of hepatocarcinoma SK-hep1 cells in vitro and in xenograft models.
Mol Cell Biochem
; 449(1-2): 207-218, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679278
7.
Effect of Qigong exercise on motor function in stroke patients: a systematic review and meta-analysis of randomized controlled trials.
Top Stroke Rehabil
; 31(3): 223-234, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489736
8.
The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.
Eur J Cancer Prev
; 33(3): 271-281, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942897
9.
Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Reprod Sci
; 30(3): 823-834, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35799022
10.
Purinergic P2X7R as a potential target for pancreatic cancer.
Clin Transl Oncol
; 25(8): 2297-2305, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856920
11.
Effect of Qigong exercise on non-motor function and life quality in stroke patients: A systematic review and meta-analysis.
Brain Behav
; 13(11): e3246, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667530
12.
Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma.
Chem Biol Drug Des
; 101(3): 794-808, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403102
13.
Phasic regulation of the ATP/P2X7 receptor signaling pathway affects the function of antigen-presenting cells in experimental autoimmune uveitis.
Int Immunopharmacol
; 119: 110241, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141671
14.
Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial.
BMJ Open
; 13(12): e078917, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070920
15.
Selection of suitable reference genes for normalization of quantitative real-time PCR in cartilage tissue injury and repair in rabbits.
Int J Mol Sci
; 13(11): 14344-55, 2012 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23203068
16.
ATP-gated P2X7 receptor as a potential target for prostate cancer.
Hum Cell
; 35(5): 1346-1354, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657562
17.
Endovascular treatment of acute ischemic stroke with a fully radiopaque retriever: A randomized controlled trial.
Front Neurol
; 13: 962987, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588884
18.
P2X7 receptor: a critical regulator and potential target for breast cancer.
J Mol Med (Berl)
; 99(3): 349-358, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486566
19.
Efficacy and Safety of a Novel Thrombectomy Device in Patients With Acute Ischemic Stroke: A Randomized Controlled Trial.
Front Neurol
; 12: 686253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34456847
20.
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
J Cancer Res Clin Oncol
; 146(11): 2731-2741, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32892231